| AbbVie AG - Tepkinly 4 mg/0,8 ml, Injektionslösung | | 69161 | | 01 | | Tepkinly 4 mg/0,8 ml | | Injektionslösung | | L01FX27 | | Epcoritamab | | 15.02.2024 | | |
| | Composition | | epcoritamabum 4 mg, natrii acetas trihydricus, acidum aceticum glaciale, sorbitolum 21.84 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 0.48 mg. | | Packungsbestandteile | | Konzentrat zur Herstellung einer Injektionslösung | | | | | | | | Active Agent | Dose |
|---|
| Epcoritamabum | 4mg / 0.8ml |
| | BAG: Active Agent | Dose |
|---|
| Epcoritamabum | 4 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Natrii Acetas Trihydricus | | | Polysorbatum 80 | | | Sorbitol | 21.84mg / 0.8ml |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 504.52 | 565.10 | A | SL | No |
|
|
